Newsroom

SEATTLE--(BUSINESS WIRE)--Parse Biosciences, le prestataire leader de services évolutifs et accessibles de séquençage unicellulaire et filiale de QIAGEN, a annoncé aujourd’hui que Xpress Genomics avait rejoint son programme Certified Service Provider (CSP), devenant ainsi la première entreprise de la région nordique à le faire. Basée à Stockholm, cette dernière sera désormais en mesure de proposer aux chercheurs son portefeuille de solutions de séquençage unicellulaire Evercode, via son pipelin...

MINNEAPOLIS--(BUSINESS WIRE)--The Board of Directors of Xcel Energy Inc. (NASDAQ: XEL) today declared a quarterly dividend on its common stock of 59.25 cents per share. The dividends are payable October 20, 2026, to shareholders of record on September 15, 2026. Xcel Energy is a major U.S. electricity and natural gas company, with operations in 8 Western and Midwestern states. Xcel Energy provides a comprehensive portfolio of energy-related products and services to 3.9 million electricity custom...

COLUMBUS, Ohio--(BUSINESS WIRE)--TeamDynamix, a leading provider of a unified, AI-powered IT Service Management platform (ITSM/ESM) with enterprise orchestration, today announced it has been positioned by Gartner® in the Challengers quadrant of the 2026 Gartner® Magic Quadrant™ for IT Service Management (ITSM) Platforms1. "We feel our position as a Challenger reflects our focus on the broader transformation happening across the enterprise technology market,” states Rod Mathews, Chief Executive...

DOVER, Del.--(BUSINESS WIRE)--Discern raised a $10 million Series A funding round after 4x ARR growth in 2025, bringing total funding to $17.5 million....

HARRISBURG, Pa.--(BUSINESS WIRE)--CJ Pony Parts Adds Scott Drake and Brothers Trucks to Its Leading Multi-Brand Restoration Platform...

SEATTLE--(BUSINESS WIRE)--Parse Biosciences, een bedrijf van QIAGEN en toonaangevende aanbieder van schaalbare, toegankelijke single-cell sequencing, maakte vandaag bekend dat Xpress Genomics toegetreden is tot zijn CSP-programma (Certified Service Provider), waarmee dit het eerste CSP-bedrijf in de Scandinavische regio wordt. Het in Stockholm gevestigde bedrijf zal onderzoekers de Evercode single-cell sequencing portfolio van Parse aanbieden via zijn bestaande sequencing servicepijplijn. Xpres...

BOULOGNE, France--(BUSINESS WIRE)--Regulatory News: FDJ UNITED (Paris:FDJU) : BU Loterie et paris sportifs en réseau France : produit brut des jeux (PBJ) de 3 429 M€ (-2,0 %) et chiffre d’affaires de 1 240 M€ (-3,9 %) La loterie a enregistré une baisse de 2,1 % du PBJ au 1er semestre, à 2 979 M€, et de 4,0 % du chiffre d’affaires, à 1 022 M€. Cette sous-performance résulte du nombre et des niveaux de jackpots élevés Euromillions nettement moins importants qu’en 2025 et, au 2e trimestre, d’une m...

WILMINGTON, Del.--(BUSINESS WIRE)--Incyte (Nasdaq:INCY) oggi ha annunciato che la Commissione europea (CE) ha approvato Opzelura® (ruxolitinib) crema per il trattamento della dermatite atopica (DA) moderata in pazienti adulti per i quali i corticosteroidi topici (TCS) e gli inibitori topici della calcineurina (TCI) non sono adeguati né adatti. "L'approvazione di Opzelura da parte della Commissione europea è una tappa importante per gli adulti in Europa che convivono con la dermatite atopica mod...

WILMINGTON, Del.--(BUSINESS WIRE)--Incyte (Nasdaq:INCY) maakte vandaag bekend dat de Europese Commissie (EC) Opzelura® (ruxolitinib) crème heeft goedgekeurd voor de behandeling van matig ernstige atopische dermatitis (AD = eczeem) bij volwassen patiënten bij wie topische corticosteroïden (TCS's) en topische calcineurineremmers (TCI's) onvoldoende of geen effect hebben. "De goedkeuring van Opzelura door de Europese Commissie is een belangrijke mijlpaal voor volwassenen in Europa die te kampen he...

BOULOGNE-BILLANCOURT, France--(BUSINESS WIRE)--Regulatory News: FDJ UNITED (Paris:FDJU): French lottery and retail sports betting BU: gross gaming revenue (GGR) of €3,429m (-2.0%) and revenue of €1,240m (-3.9%) The lottery reported a 2.1% decline in GGR in the first half of the year, to €2,979m, and a 4.0% decline in revenue, to €1,022m. This underperformance is due to the significantly lower number and amounts of major Euromillions jackpots compared to 2025 and, in the second quarter, lower tr...